Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001041288 | SCV001204893 | uncertain significance | Nephronophthisis 9 | 2019-11-28 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with leucine at codon 312 of the NEK8 protein (p.Ser312Leu). The serine residue is highly conserved and there is a large physicochemical difference between serine and leucine. This variant is present in population databases (rs200212844, ExAC 0.01%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals with NEK8-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002489570 | SCV002801298 | uncertain significance | Nephronophthisis 9; Renal-hepatic-pancreatic dysplasia 2 | 2022-02-01 | criteria provided, single submitter | clinical testing |